VANCOUVER, BC, CANADA (April 13, 2020) – Mota Ventures Corp. (CSE:MOTA FSE: 1WZ:GR OTC: PEMTF) (the “Company”) is excited to announce its First Class CBD and Nature’s Exclusive brands acquired over 6,000 new customers from April 1st through April 11th.  Additionally, during this time period over 1,700 of the new customers purchased products from the Immune Support line.  During the month of March, the Company experienced a record number of new customers enrolling in a monthly subscription, totaling 18,962.

The Immunity Blend is currently the Company’s top seller in the Immune Support line.  The all-natural blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano.  The line also features Immune CBD oil containing CBD, B3, B12, Vitamin C and Zinc and Immunity Gummy Bears contain 100% natural Elderberry extract.

First Class and Nature’s Exclusive offer a CBD hemp-oil formulation intended to provide users with the therapeutic benefits that hemp may offer.  The hemp oil used in the products is derived from hemp grown and cultivated in the United States.  The extraction process is designed to maintain all the beneficial qualities that hemp may offer.  First Class and Nature’s Exclusive offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee.  The Company plans to continue its significant growth in U.S. operations over the balance of 2020, as well as an expansion into the European market.

“I am pleased at the incredible number of monthly subscriptions acquired during the month of March.  We continue to see overwhelming interest in our Immune Support products and higher CBD content oils.  We operate a very responsive and agile business, which allows us to identify consumer trends and execute upon the demand we are seeing in the marketplace,” stated Ryan Hoggan, CEO of the Company.

About Mota Ventures Corp.

Mota Ventures is an established eCommerce direct to consumer provider of a wide range of CBD products in the United States and Europe.  In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its First Class CBD and Nature’s Exclusive brands.  Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom.  Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products.  Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.


Ryan Hoggan

Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at or

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to the sale and marketing of products under the First Class CBD and Nature’s Exclusive brands, its plans to become a vertically integrated global CBD brand, its plans to cultivate and extract cannabis to produce CBD and high-quality value added CBD products in Latin America for distribution domestically and internationally and its plans to acquire revenue-producing CBD brands and operations in Europe and North America. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.